Second Sight Medical Prod... (EYES)
NASDAQ: EYES
· Real-Time Price · USD
4.14
-0.22 (-5.05%)
At close: Aug 31, 2022, 4:00 AM
Second Sight Medical Products Revenue Breakdown
Period Ending | Dec 31, 2018 |
---|---|
Argus I I Product Revenue | 6.9M |
Argus I I Product Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.13M | 1.47M | 975K | 1.53M | 1.34M | 2.47M | 1.34M | 1.06M | 1.52M | 2.72M | 3.34M | 3.49M | 3.94M | 4.55M | 4.89M | 5.37M | 5.51M | 6.25M | 5.27M | 4.9M | 5.35M | 4.98M | 4.96M | 4.87M | 4.82M | 4.42M | 4.65M | 4.56M | 4.3M | 3.65M |
Selling, General, and Administrative Revenue Growth | +44.95% | +50.36% | -36.27% | +14.35% | -45.87% | +83.93% | +26.55% | -29.95% | -44.31% | -18.60% | -4.07% | -11.63% | -13.33% | -6.89% | -8.99% | -2.52% | -11.89% | +18.60% | +7.57% | -8.32% | +7.48% | +0.30% | +1.93% | +1.00% | +8.98% | -4.99% | +2.17% | +5.98% | +17.73% | n/a |
Research and Development Revenue | 843K | 645K | 644K | 697K | 695K | 334K | 347K | 279K | 323K | 3.89M | 4.14M | 3.38M | 3.44M | 2.18M | 2.44M | 2.67M | 2.42M | 2.47M | 2.27M | 1.83M | 1.95M | 1.85M | 2.08M | 1.59M | 916K | 762K | 546.56K | 592.82K | 848.76K | 1.05M |
Research and Development Revenue Growth | +30.70% | +0.16% | -7.60% | +0.29% | +108.08% | -3.75% | +24.37% | -13.62% | -91.69% | -6.22% | +22.67% | -1.66% | +57.40% | -10.46% | -8.76% | +10.32% | -2.10% | +8.94% | +24.37% | -6.31% | +5.52% | -11.24% | +31.05% | +73.36% | +20.21% | +39.42% | -7.80% | -30.15% | -19.00% | n/a |